By McCord Pagan ( May 15, 2020, 7:04 PM EDT) -- Swiss oncology firm ADC Therapeutics SA saw a strong debut Friday on the New York Stock Exchange, with shares closing more than 50% above its already upsized initial public offering price of $19 each, making it likely the company will exceed its target of $233 million....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.